INSP logo

INSPIRE MEDICAL SYSTEMS INC

INSPNYSE
πŸ† #1985 by market capEarnings Nov 2 Β· PostUS Equity
$73.00β–² $3.09 (+4.23%)
Market closed Β· at close
πŸ””
Track INSP
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 4.2%
7dβ–² 5.6%
14dβ–² 0.2%
30dβ–² 16.0%
ytdβ–Ό 20.8%
1yβ–Ό 1.6%
🏦Market Cap
$2.11B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+13.6%
Healthy
πŸ“ŠGross Margin
86.1%
High
πŸ’΅FCF Margin
13.0%
Healthy
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$72.25 – $74.08
52-Week Range
$38.91 – $147.03
Volume
$1.88B
Avg Volume
$1.49B
Shares Outstanding
28.9M
Next Earnings
Nov 26, 2026

Fundamentals Snapshot

Annual Revenue
$912M
Last Q Revenue
$201M
P/E Ratio
15.0
P/S Ratio
2.3x
EPS (TTM)
$4.68
Dividend Yield
0.00%
Dilution (1yr)
βˆ’5.0%

Why Investors Own INSP

  • βœ“High-growth profile β€” revenue up +1.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 72% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INSP logo

INSPIRE MEDICAL SYSTEMS INC

INSP
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$912Mβ–² +13.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
85.4%β–² +0.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$51Mβ–² +41.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$78Mβ–Ό βˆ’13.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
29.2Mβ–Ό βˆ’5.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$43Mβ–Ό βˆ’$76M YoY
StockOtter Β· stockotter.space

About INSPIRE MEDICAL SYSTEMS INC

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$92.48
β–² +26.7% Upside
High Target$104.17
Low Target$86.00
Based on 12 analysts

Latest News & Updates